Department of Orthopedic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China.
Orthopedic Department of The Third People's Hospital of Jingdezhen, Jiangxi, 333000, China.
J Control Release. 2024 Dec;376:999-1013. doi: 10.1016/j.jconrel.2024.11.002. Epub 2024 Nov 7.
Nanozymes, known for their high efficiency in scavenging reactive oxygen species (ROS), have received significant attention in promoting the healing of infected wounds. Herein, we reported a novel multifunctional PDA-PtCuTe nanozyme with excellent ROS scavenging, antibacterial, pro-angiogenic, anti-inflammatory, and immune regulatory properties. It was loaded onto microneedles (PTPP-MN) for treating infected wounds. In vitro experiments demonstrated its ability to scavenge ROS and exhibit antioxidant properties. Compared to PT-MN (11.03 ± 3.37 %) and PTP-MN (42.30 ± 2.60 %), the ROS scavenging rate of PTPP-MN reached 63.63 ± 4.42 %. The microneedle exhibits good biocompatibility, stimulating fibroblast migration, endothelial angiogenesis, and M2 macrophage polarization. Additionally, it effectively eliminates ROS and provides antioxidant effects while inhibiting the viability of S. aureus and E. coli. Animal experiments showed that the PTPP-MN group achieved near-complete re-epithelialization by the third day compared to other groups. Histological observations revealed that the PTPP-MN group exhibited enhanced granulation tissue formation, epithelial regeneration, and angiogenesis. After PTPP-MN treatment, the local immune response shifted from a pro-inflammatory state to a pro-regenerative state. Our results indicate that PTPP-MN holds great promise for infected wound healing with reduced scar formation.
纳米酶因其高效清除活性氧 (ROS) 的能力而备受关注,在促进感染性伤口愈合方面得到了广泛的关注。本文报道了一种新型多功能 PDA-PtCuTe 纳米酶,具有出色的 ROS 清除、抗菌、促血管生成、抗炎和免疫调节特性。它被负载到微针 (PTPP-MN) 上用于治疗感染性伤口。体外实验表明,它具有清除 ROS 和抗氧化的能力。与 PT-MN(11.03±3.37%)和 PTP-MN(42.30±2.60%)相比,PTPP-MN 的 ROS 清除率达到 63.63±4.42%。微针具有良好的生物相容性,能刺激成纤维细胞迁移、内皮血管生成和 M2 巨噬细胞极化。此外,它能有效清除 ROS 并提供抗氧化作用,同时抑制金黄色葡萄球菌和大肠杆菌的活力。动物实验表明,与其他组相比,PTPP-MN 组在第三天就实现了近乎完全的再上皮化。组织学观察显示,PTPP-MN 组表现出增强的肉芽组织形成、上皮再生和血管生成。经 PTPP-MN 治疗后,局部免疫反应从促炎状态转向促再生状态。我们的结果表明,PTPP-MN 有望用于治疗感染性伤口,减少疤痕形成。